Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - APPLIED DNA SCIENCES INC | t80973_10k.htm |
| EX-23.2 - EXHIBIT 23.2 - APPLIED DNA SCIENCES INC | t80973_ex23-2.htm |
| EX-10.30 - EXHIBIT 10.30 - APPLIED DNA SCIENCES INC | t80973_ex10-30.htm |
| EX-23.1 - EXHIBIT 23.1 - APPLIED DNA SCIENCES INC | t80973_ex23-1.htm |
| EX-31.1 - EXHIBIT 31.1 - APPLIED DNA SCIENCES INC | t80973_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - APPLIED DNA SCIENCES INC | t80973_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - APPLIED DNA SCIENCES INC | t80973_ex31-2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - APPLIED DNA SCIENCES INC | Financial_Report.xls |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Applied DNA Sciences, Inc. (the “Company”) for the fiscal year ended September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Karol Kain Gray, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Karol Kain Gray
|
||
|
Karol Kain Gray
|
||
|
Chief Financial Officer
|
||
|
Date: December 15, 2014
|
|
*
|
A signed original of this written statement required by Section 906 has been provided to Applied DNA Sciences, Inc. and will be retained by Applied DNA Sciences, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
|